Why you should not take tamoxifen?
Why you should not take tamoxifen?
Tamoxifen’s selective estrogen activation effects can cause some serious side effects, including blood clots, stroke, and endometrial cancer. If you and your doctor are considering tamoxifen as part of your treatment plan, tell your doctor if you smoke or have a history of blood clots or heart attack.
Is aromatase inhibitor better than tamoxifen?
5 years of an aromatase inhibitor reduces 10-year breast cancer mortality rates by about 15% compared with 5 years of tamoxifen, hence by about 40% (proportionately) compared with no endocrine treatment.
Is letrozole better than tamoxifen?
Background. The aromatase inhibitor letrozole is a more effective treatment for metastatic breast cancer and more effective in the neoadjuvant setting than tamoxifen. We compared letrozole with tamoxifen as adjuvant treatment for steroid-hormone-receptor–positive breast cancer in postmenopausal women.
Is there an alternative drug to tamoxifen?
Earlier ATAC results found that Arimidex was more effective than tamoxifen in reducing the risk of recurrence of early-stage, hormone-receptor-positive breast cancer in postmenopausal women. Other studies comparing tamoxifen to the other two aromatase inhibitors (Aromasin and Femara) have shown similar results.
What can I take instead of anastrozole?
Two other aromatase inhibitors, exemestane and letrozole, can be used instead of anastrozole to help reduce your risk of breast cancer recurrence.
Is there a alternative to tamoxifen?
After 10 years of follow-up, a study shows that taking Arimidex for 5 years is better at reducing the risk of hormone-receptor-positive breast cancer recurrence than taking tamoxifen for 5 years.
Has anyone stopped taking tamoxifen?
Janice Hopkins Tanne. A large Irish study of women who were prescribed tamoxifen showed that 22.1% had stopped taking the drug within a year (Cancer 2007 Jan 27, doi: 10.1002/cncr. 22486). Within 3.5 years, the number who had stopped had risen to 35.2%.
What can I take instead of tamoxifen?
Arimidex Still Better Than Tamoxifen After Surgery to Reduce Recurrence Risk
- Arimidex (chemical name: anastrozole)
- Aromasin (chemical name: exemestane)
- Femara (chemical name: letrozole)
Which has more side effects letrozole or tamoxifen?
Letrozole was associated with a significantly lower rate of vaginal bleeding and thromboembolic events. However, bone fractures and adverse cardiovascular events were more frequent in the arm receiving letrozole than in the arm receiving tamoxifen but these differences were not statistically significant.
How much does tamoxifen reduce the risk of recurrence?
Doctors have long known that five years of tamoxifen reduces recurrence by about half during treatment and by nearly a third over the next five years. Aromatase inhibitors, which work only in postmenopausal women, are even more effective than tamoxifen at reducing recurrence and death from breast cancer.
